NPM1 is usually a secondary or downstream mutation, whereas mutations in DNMT3A, ASXL1, IDH1/2, and TET2 occur very early during clonal evolution but are typically not sufficient to cause leukemia on their own. Here, NPM1 is linked to leukemia.